Pfizer: Booster shots more effective at stopping omicron by ’25-fold’

Published



Getting your booster may help you defend against COVID-19’s omicron variant.

Booster shots of Pfizer’s COVID-19 vaccine significantly improve one’s odds against the new omicron variant, increasing the neutralizing antibody titers by 25-fold compared to the initial two doses, according to lab tests conducted by the company.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.